BR
BioArctic AB
BRCTF · OTC
$36.92 +0.00% (+$0.00)
Market Cap 32.7B kr
P/E Ratio 309.13x
Div. Yield 0.59%
ROE 5.21%
Bulios Fair Price
$26.8
27.4% downside
Current Price
$36.92
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BRCTF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive EV/EBITDA 143.35x
P/S 32.66x
P/B 16.34x
Growth
100 /100
Growing Book val. growth 35.64%
Rev. growth 105.95%
FCF growth N/A
Profitability
80 /100
Strong Net margin 10.56%
Op. margin 21.42%
FCF margin 10.61%
Quality
25 /100
Poor ROE 5.21%
ROA 3.78%
Asset turnover 0.36x
Debt
100 /100
Low Current ratio 3.99x
Int. coverage 32.03x
Net debt/EBITDA -4.45x
Stability
16 /100
Unstable Rev. volatility 375.16%
EPS volatility 1,146.35%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BRCTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gunilla Christina Osswald
Employees
131
Headquarters
Stockholm
Upcoming events
25 NOV
Earnings
Upcoming earnings report